Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masami Tanaka

Showing results (11-20 of 264) with videos related to

Pageof 27
Sort By:
Rinsho Shinkeigaku = Clinical Neurology|July 10, 2015
[Natalizumab treatment in multiple sclerosis]Masami Tanaka
Metabolism Open|February 24, 2022
"Greedy Organs Hypothesis" for sugar and salt in the pathophysiology of non-communicable diseases in relation to sodium-glucose co-transporters in the intestines and the kidneyHiroshi Itoh, Masami Tanaka
Journal of Diabetes and Its Complications|June 25, 2010
Improvement in bedtime plasma glucose level serves as a predictor of long-term blood glucose control in patients with Type 2 diabetes: a study with monotherapy of 50/50 premixed insulin analogue three times daily injectionMasami Tanaka, Hitoshi Ishii
Journal of Neuroimmunology|April 8, 2014
Anti-MOG antibodies in adult patients with demyelinating disorders of the central nervous systemMasami Tanaka, Keiko Tanaka
Endocrinology and Metabolism (Seoul, Korea)|December 29, 2016
Nonalbuminuric Renal Insufficiency: Can It Be a Novel Category of Diabetic Nephropathy?Masami Tanaka, Hiroshi Itoh
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|November 18, 2015
[Hypertension: The Points of Management of Hypertension for All Physicians--Based on the JSH 2014 Hypertension Guidelines--. Topics: V. Points of hypertension treatment for the patients complicated by kidney diseases and diabetes]Masami Tanaka, Hiroshi Itoh
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2014
[Pathogenesis of autoantibodies in demyelinating disorders of the central nervous system]Keiko Tanaka, Masami Tanaka
Journal of Neuroimmunology|November 5, 2015
Daily fingolimod administration may cause lymphopenia but alternate-day administration may be too little to inhibit disease activityMasami Tanaka, Masako Kinoshita
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Comparison of nadir serum concentrations in the extended dosing therapy of natalizumab between American and Japanese multiple sclerosis patientsMasami Tanaka, Kaho Yokoyama
Creative Nursing|October 3, 2025
Mothers' Experiences of Providing Complex Home-Based Care for Children with Profound Intellectual and Multiple Disabilities: A Phenomenological StudyMasami Tanaka, Yuta Koto
Pageof 27

Showing results (11-20 of 264) with videos related to

Sort By:
Pageof 27
Rinsho Shinkeigaku = Clinical Neurology|July 10, 2015
[Natalizumab treatment in multiple sclerosis]Masami Tanaka
Metabolism Open|February 24, 2022
"Greedy Organs Hypothesis" for sugar and salt in the pathophysiology of non-communicable diseases in relation to sodium-glucose co-transporters in the intestines and the kidneyHiroshi Itoh, Masami Tanaka
Journal of Diabetes and Its Complications|June 25, 2010
Improvement in bedtime plasma glucose level serves as a predictor of long-term blood glucose control in patients with Type 2 diabetes: a study with monotherapy of 50/50 premixed insulin analogue three times daily injectionMasami Tanaka, Hitoshi Ishii
Journal of Neuroimmunology|April 8, 2014
Anti-MOG antibodies in adult patients with demyelinating disorders of the central nervous systemMasami Tanaka, Keiko Tanaka
Endocrinology and Metabolism (Seoul, Korea)|December 29, 2016
Nonalbuminuric Renal Insufficiency: Can It Be a Novel Category of Diabetic Nephropathy?Masami Tanaka, Hiroshi Itoh
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|November 18, 2015
[Hypertension: The Points of Management of Hypertension for All Physicians--Based on the JSH 2014 Hypertension Guidelines--. Topics: V. Points of hypertension treatment for the patients complicated by kidney diseases and diabetes]Masami Tanaka, Hiroshi Itoh
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2014
[Pathogenesis of autoantibodies in demyelinating disorders of the central nervous system]Keiko Tanaka, Masami Tanaka
Journal of Neuroimmunology|November 5, 2015
Daily fingolimod administration may cause lymphopenia but alternate-day administration may be too little to inhibit disease activityMasami Tanaka, Masako Kinoshita
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Comparison of nadir serum concentrations in the extended dosing therapy of natalizumab between American and Japanese multiple sclerosis patientsMasami Tanaka, Kaho Yokoyama
Creative Nursing|October 3, 2025
Mothers' Experiences of Providing Complex Home-Based Care for Children with Profound Intellectual and Multiple Disabilities: A Phenomenological StudyMasami Tanaka, Yuta Koto
Pageof 27